MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma
Open accessThe DOI matches its Crossref record.
Abstract
// Kyosuke Matsuzaki 1 , Kazutoshi Fujita 1 , Kentaro Jingushi 2 , Atsunari Kawashima 1 , Takeshi Ujike 1 , Akira Nagahara 1 , Yuko Ueda 2 , Go Tanigawa 3 , Iwao Yoshioka 4 , Koji Ueda 5 , Rikinari Hanayama 6 , Motohide Uemura 1 , Yasushi Miyagawa 1 , Kazutake Tsujikawa 2 , Norio Nonomura 1 1 Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan 2 Laboratory of Molecular and Cellular Physiology, Osaka University Graduate School of Pharmaceutical Science, Osaka, Japan 3 Department of Urology, Osaka General Medical Center, Osaka, Japan 4 Department of Urology, Osaka Police Hospital, Osaka, Japan 5 Cancer Proteomics Group, Genome Center, Japanese Foundation for Cancer Research, Tokyo, Japan 6 Department of Immunology, Kanazawa University Graduate School of Medical Sciences, Ishikawa, Japan Correspondence to: Kazutoshi Fujita, email: kazufujita2@gmail.com Keywords: extracellular vesicles, urothelial carcinoma, microRNA, urine, biomarker Received: August 08, 2016 Accepted: January 10, 2017 Published: February 01, 2017 ABSTRACT Background: Extracellular vesicles are lipid bilayer vesicles containing protein, messengerRNA and microRNA. Cancer cell-derived extracellular vesicles may be diagnostic and therapeutic targets. We extracted extracellular vesicles from urine of urothelial carcinoma patients and the control group to identify cancer-specific microRNAs in urinary extracellular vesicles as new biomarkers. Materials and methods: microRNA from urinary extracellular vesicles extracted from 6 urothelial carcinoma patients and 3 healthy volunteers was analyzed. We verified candidate microRNAs in an independent cohort of 60 urinary extracellular vesicles samples. To normalize the microRNA expression level in extracellular vesicles, we examined the following in extracellular vesicles: protein concentration, CD9 intensity, amounts of whole miRNAs, RNA U6B small nuclear expression and the creatinine concentration of original urine correlating with the counts of extracted extracellular vesicles measured by the NanoSight™ system. Results: From the microarray results 5 microRNAs overexpressed in urinary extracellular vesicles of urothelial carcinoma patients were identified. Creatinine concentration of original urine correlated most with particle counts of extracellular vesicles, indicating that creatinine could be a new tool for normalizing microRNA expression. MiR-21-5p was the most potent biomarker in urinary extracellular vesicles (sensitivity, 75.0%; specificity, 95.8%) and was also overexpressed in urinary extracellular vesicles from urothelial carcinoma patients with negative urine cytology. For the subgroup with negative urine cytology, the sensitivity was 75.0% and specificity was 95.8%. Conclusion: MiR-21-5p in urinary extracellular vesicles could be a new biomarker of urothelial carcinoma, especially for urothelial carcinoma patients with negative urine cytology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Application of exosomes as liquid biopsy in clinical diagnosis
Zhou, B., Xu, K., Zheng, X., Chen, T., Wang, J., Song, Y., Shao, Y., & Zheng, S. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00258-9 · Cited by 685
Wang, W., Li, D.-B., Li, R.-Y., Zhou, X., Yu, D.-J., Lan, X.-Y., Li, J.-P., & Liu, J.-L. (2018) · Cerebrovascular Diseases · doi:10.1159/000488365 · Cited by 113
Huang, Q., Yang, J., Zheng, J., Hsueh, C., Guo, Y., & Zhou, L. (2018) · Oncology Reports · doi:10.3892/or.2018.6672 · Cited by 19
Metadata
- Authors
- Matsuzaki, K., Fujita, K., Jingushi, K., Kawashima, A., Ujike, T., Nagahara, A., Ueda, Y., Tanigawa, G., Yoshioka, I., Ueda, K., Hanayama, R., Uemura, M., Miyagawa, Y., Tsujikawa, K., & Nonomura, N.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-02-01
- Volume
- 8
- Issue
- 15
- Pages
- 24668-24678
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2583952514
- Cited by
- 104
- References
- 0
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.